Publications by authors named "Ilva D Rupenthal"

Claim this Profile
I
Inhibiting the NLRP3 inflammasome pathway: An effective way to treat chronic inflammation in experimental autoimmune uveitis.
Avik Shome, Odunayo O Mugisho, Priyanka Agarwal, Rachael L Niederer, Ilva D Rupenthal

Eur J Pharmacol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of vitreous derived small extracellular vesicles in diabetic retinopathy.
Henry H Louie, Ilva D Rupenthal, Julie C Lim, Lawrence W Chamley, Odunayo O Mugisho

Exp Eye Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small Extracellular Vesicles Released from ARPE-19 Cells Grown under Diabetic Retinopathy Conditions Promote NLRP3 Inflammasome Activation.
Henry H Louie, Odunayo O Mugisho, Lawrence W Chamley, Ilva D Rupenthal

ACS Biomater Sci Eng· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced ocular retention and intraocular pressure-lowering efficacy of hydrophobic microspheres for glaucoma treatment.
Qinyu Li, Bowen Pan, Kangyiran Pan, Yangrong Zhang, Ilva D Rupenthal

Colloids Surf B Biointerfaces· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transfersomes: a next-generation drug delivery system for topical ocular drug delivery.
Santosh Bhujbal, Ilva D Rupenthal, Vandana B Patravale, Priyanka Agarwal

Expert Opin Drug Deliv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of tear fluid properties on physicochemical, mucoadhesion and ocular penetration characteristics of transfersomes.
Santosh Bhujbal, Priyanka Agarwal, Soma Sengupta, Cornelia M Keck, Ilva D Rupenthal

Eur J Pharm Biopharm· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The NLRP3 inflammasome pathway contributes to chronic inflammation in experimental autoimmune uveitis.
Avik Shome, Ilva D Rupenthal, Rachael L Niederer, Odunayo O Mugisho

Animal Model Exp Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formulation and characterization of transfersomes for ocular delivery of tonabersat.
Santosh Bhujbal, Ilva D Rupenthal, Priyanka Agarwal

Pharm Dev Technol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of ocular tolerability and bioavailability of tonabersat transfersomes ex vivo.
Santosh Bhujbal, Ilva D Rupenthal, Priyanka Agarwal

Drug Deliv Transl Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and delivery effect of prolonged-retention dexamethasone and tacrolimus microcrystals eye drops.
Ji Huang, Siying Yuan, Jinlan Mao, Kangyiran Pan, Li Liu, Ilva D Rupenthal

Int J Pharm· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation in Dry Eye Disease-Pathogenesis, Preclinical Animal Models, and Treatments.
Santosh Bhujbal, Ilva D Rupenthal, Philipp Steven, Priyanka Agarwal

J Ocul Pharmacol Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of transferosomes for topical ocular drug delivery of curcumin.
Geisa Nascimento Barbalho, Stefan Brugger, Christian Raab, Jara-Sophie Lechner, Taís Gratieri, Ilva D Rupenthal

Eur J Pharm Biopharm· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a stability-indicating HPLC method for assay of tonabersat in pharmaceutical formulations.
Santosh Bhujbal, Ilva D Rupenthal, Priyanka Agarwal

Methods· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilizing an Ex Vivo Skin Penetration Analysis Model for Predicting Ocular Drug Penetration: A Feasibility Study with Curcumin Formulations.
Christian Raab, Stefan Brugger, Jara-Sophie Lechner, Geisa Nascimento Barbalho, Taís Gratieri, Ilva D Rupenthal

Pharmaceutics· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of Ocular Penetration of Lipophilic Drugs from Lipophilic Vehicles.
Carmen Liu, Jack Jonathan Maran, Ilva D Rupenthal, Priyanka Agarwal

J Pharm Sci· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress in Ocular Drug Delivery: Challenges and Constraints.
Ilva D Rupenthal, Priyanka Agarwal

Handb Exp Pharmacol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physicochemical properties and micro-interaction between micro-nanoparticles and anterior corneal multilayer biological interface film for improving drug delivery efficacy: the transformation of tear film turnover mode.
Huamei Li, Fuda Dai, Hanyu Liu, Qi Tao, Jie Hu, Ilva D Rupenthal

Drug Deliv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-aqueous formulations in topical ocular drug delivery - A paradigm shift?
Priyanka Agarwal, Ilva D Rupenthal

Adv Drug Deliv Rev· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical characterization of water-free cyclosporine eye drops - Factors impacting ocular penetration ex vivo and in vivo.
Priyanka Agarwal, Johannes Korward, Sonja Krösser, Ilva D Rupenthal

Eur J Pharm Biopharm· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Grading System for Experimental Autoimmune Uveitis in Mice.
Avik Shome, Odunayo O Mugisho, Rachael L Niederer, Ilva D Rupenthal

Biomedicines· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NLRP3 Inflammasome as a Potential Therapeutic Target in Dry Eye Disease.
Dian Zhuang, Stuti L Misra, Odunayo O Mugisho, Ilva D Rupenthal, Jennifer P Craig

Int J Mol Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orally Delivered Connexin43 Hemichannel Blocker, Tonabersat, Inhibits Vascular Breakdown and Inflammasome Activation in a Mouse Model of Diabetic Retinopathy.
Odunayo O Mugisho, Jyoti Aryal, Avik Shome, Heather Lyon, Monica L Acosta, Ilva D Rupenthal

Int J Mol Sci· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular Vesicles as Biomarkers and Therapeutics for Inflammatory Eye Diseases.
Henry H Louie, Odunayo O Mugisho, Lawrence W Chamley, Ilva D Rupenthal

Mol Pharm· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical Evaluation of Multifunctional Betaxolol Hydrochloride Nanoformulations for Effective Sustained Intraocular Pressure Reduction.
Jie Hu, Huihui Li, Yingshan Zhao, Yuancheng Ke, Ilva D Rupenthal

Int J Nanomedicine· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of NLRP3 Inflammasome Activation in the Onset of Diabetic Retinopathy.
Charisse Y-J Kuo, Jack J Maran, Emma G Jamieson, Ilva D Rupenthal, Rinki Murphy

Int J Mol Sci· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis